GX Genomics & Biotechnology ETF (GNOM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GNOM | ||||
| Company | GX Genomics & Biotechnology ETF | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 47.43 | ||||
| High | 47.43 | ||||
| Low | 47.13 | ||||
| Latest | 47.20 | ||||
| Change | -0.44 | ||||
| % Change | -0.93% | ||||
| Volume | 3,500 | ||||
| 20-Day Average Volume | 14,440 | ||||
| Previous Close | 47.65 | ||||
| Industry | N/A | ||||
| Has Options | Yes | ||||
| Technicals | |||||
| 20-Day Moving Average | 46.76 | ||||
| 20-Day Raw Stochastic | 70.94% | ||||
| 20-Day Relative Strength | 58.88 | ||||
| Weighted Alpha | +32.80 | ||||
| Today's Opinion | 100% Buy | ||||
| Previous Opinion | 100% Buy | ||||
| Last Month's Opinion | 100% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.15% since 12/18/25 | ||||
| Low | 46.14 on 12/19/25 | ||||
| High | 48.09 on 12/22/25 | ||||
| 1-Month | |||||
| %Chg | +1.96% since 11/26/25 | ||||
| Low | 45.04 on 12/02/25 | ||||
| High | 48.09 on 12/22/25 | ||||
| 3-Month | |||||
| %Chg | +24.64% since 09/26/25 | ||||
| Low | 38.10 on 09/30/25 | ||||
| High | 48.09 on 12/22/25 | ||||
| 6-Month | |||||
| %Chg | +40.40% since 06/26/25 | ||||
| Low | 33.38 on 06/27/25 | ||||
| High | 48.09 on 12/22/25 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 57,589 | ||||
| Shares Outstanding, K | 1,220 | ||||
| Annual Sales | 19,340,000 | ||||
| Annual Net Income | -72,340,000 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | 1.22 | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | 03/19/13 | ||||
| Most Recent Dividend | 0.033 on 06/27/25 | ||||
| Next Ex-Dividends Date | 06/27/25 | ||||
| Ratios | |||||
| Price/Earnings ttm | -17.21 | ||||